Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gu-ran Yu"'
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 18 (2024)
Background: Nintedanib and pirfenidone are preferred pharmacological therapies for patients with idiopathic pulmonary fibrosis (IPF). However, evidence favoring antifibrotic therapy in patients with non-IPF fibrosing interstitial lung diseases (ILD)
Externí odkaz:
https://doaj.org/article/88de87548d944e3a9f6f57f2a91c829d
Publikováno v:
Pharmaceutical Biology, Vol 60, Iss 1, Pp 2210-2218 (2022)
Context Catalpol is a major bioactive constituent of Rehmannia glutinosa Libosch (Scrophulariaceae), a traditional Chinese medicine, which is widely used in multiple diseases, including hypertension.Objectives To explore whether catalpol protects aga
Externí odkaz:
https://doaj.org/article/aa3f218b2ebc427da3b37031b2286109
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Hypertension and its associated dysfunction of the blood-brain barrier (BBB) are considered to contribute to cerebral small vessel disease (cSVD). Angiotensin II (Ang II), as an important vasoactive peptide of the renin-angiotensi
Externí odkaz:
https://doaj.org/article/580ead57574748f6b016eff46fb3c359
Publikováno v:
European Journal of Gastroenterology & Hepatology; Aug2024, Vol. 36 Issue 8, p1046-1053, 8p
Publikováno v:
Phytotherapy Research. 35:6241-6254
Hypertension and its associated dysfunction of the blood-brain barrier (BBB) contribute to cerebral small vessel disease (cSVD). Angiotensin II (Ang II), a vasoactive peptide of the renin-angiotensin system (RAS), is not only a pivotal molecular sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87f86d59559adf6701452abb30a24f30
https://doi.org/10.1002/ptr.7269
https://doi.org/10.1002/ptr.7269
Autor:
Liang-Yong Li, Huai-Zhen Chen, Shan Jin, Shen-Wei Cui, Lu-Lu Tang, Dao-Jun Xie, Wen-Ming Yang, Gu-Ran Yu, Jing Zhang
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Objective. Gandouling (GDL) tablet is a Chinese patent medicine approved by the National Medical Product Administration, which is used to treat Wilson disease (WD) in China. In this study, we aimed to investigate the effects of GDL on mitophagy in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4908287eeaa9db4a364c56819639db81
https://doi.org/10.1155/2020/3183714
https://doi.org/10.1155/2020/3183714
Autor:
Min-Ye Huang, Gu-Ran Yu
Publikováno v:
Journal of Asian Natural Products Research. 23:556-569
This study aimed to evaluate the effect Cycloastragenol (CAG), a triterpenoid saponin isolated from the Radix astragali, on Aβ-induced BBB damage. An immortalized endothelial cell line (bEnd.3) was...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9aa3b0ae5fadcf2f38eb2fba9b9c95d
https://doi.org/10.1080/10286020.2020.1786372
https://doi.org/10.1080/10286020.2020.1786372
Autor:
Min-Ye, Huang, Gu-Ran, Yu
Publikováno v:
Journal of Asian natural products research. 23(6)
This study aimed to evaluate the effect Cycloastragenol (CAG), a triterpenoid saponin isolated from the Radix astragali, on Aβ-induced BBB damage. An immortalized endothelial cell line (bEnd.3) was employed to mimic a BBB. The Western blot, TUNEL st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07219b051df63bec46a67f888e0d04ba
https://pubmed.ncbi.nlm.nih.gov/32608254
https://pubmed.ncbi.nlm.nih.gov/32608254